The GLP is committed to full transparency. Download and review our Annual Report.

The GLP is committed to full transparency. Download and review our Annual Report.

Canada launches new safety review of AquAdvantage GMO salmon

CBC News has learned AquaBounty’s genetically modified salmon is going through a new federal risk assessment.

Environment and Climate Change Canada says the risk assessment comes after the company notified Ottawa in July about its plans to build a new egg production and grow-out facility in Rollo Bay West, [Prince Edward Island] P.E.I. Previously the company was producing a limited number of eggs in its facility in Bay Fortune, P.E.I.

AquaBounty Technologies now wants to produce 250 metric tonnes of its AquAdvantage salmon for commercial sale in Canada and export. The company’s salmon grow twice as quickly as conventionally reared Atlantic farmed salmon.

Initially, in May 2017, Environment Canada told CBC News the new project would not require an additional federal environmental assessment, but by July 2017, that position had changed. “Should AquaBounty wish to manufacture or grow out the AquAdvantage salmon at this site, a new notification will be required,” Minister Catherine McKenna wrote.

Related article:  Current biotech regulations create animal and crop approval blocks and bottlenecks but gene editing may open new doors

According to Environment and Climate Change Canada, AquaBounty volunteered to participate in a public engagement process as part of this latest risk assessment. That process accepts scientific input from stakeholders.

Read full, original article: GMO salmon undergoing another federal risk assessment

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend